Rheumatoid arthritis (RA) is a systemic disorder of unknown aetiology involving especially the joints. It is characterised by persistent immunological abnormalities, including the formation of various autoantibodies. Antibodies to a variety of self-antigens including immunoglobulins,' collagen,23 smooth muscle,4 intermediate filaments,5 nuclear antigens,67 and fibroblasts8 have been identified in the sera and joint fluids of patients with RA. The pathogenic significance of most of these antibodies has yet to be determined.
A significant proportion of RA patients show clinical, echocardiographic, and histological signs of cardiac disease.9 It was therefore of interest to screen RA sera for the presence of antibodies reactive with cardiac antigens present on cultured neonatal rat heart cells, a popular and convenient substrate for various physiological, biochemical, pharmacological, and cardiological studies.
Materials and methods
Patients and sera. Twenty-three patients with no clinical evidence of ischaemic heart disease attending an outpatient rheumatology clinic with classical or definite RA, and 4 additional patients with probable RA, were studied. The patients' ages ranged from 25 to 67 years, the male to female ratio was 1:4-4, and the mean disease duration was 11 years (range Accepted for publication 27 September 1983. Correspondence to Dr R. More Rheumatoid factor activity was absorbed with glutaraldehyde polymerised pooled human gamma globlin (40% saturated ammonium sulphate fraction) as described above.
Results
Anti-nM reactivity was detected in the sera of 22 out of 27 patients with RA and in only 2 out of 20 healthy controls, a highly significant finding (p<0001). Since the immunofluorescent staining was carried out routinely with living cells (94-98% viability as determined by either trypan blue exclusion or fluorescein diacetate fluorochromasia) the recognised antigen was surface associated. The fluorescence pattern was usually patchy or beaded (Fig. 1) There was an increased prevalence of immunofluorescent positivity in the group of patients with active disease (21 out of 23) as compared with 1 out of 4 in the quiescent patients, while no significant difference was found between rheumatoid factor seropositive and seronegative patients. Three out of 27 RA sera reacted with cultured M cells, while 7 additional sera were marginally reactive. Reactivity with M cells was independent of that with nM cells.
The class of antibodies reacting with the cultured nM cells was determined for pooled RA sera by indirect immunofluorescence. The main reactivity was found with anti-IgG, while some reactivity was also detected with anti-IgM and anti-IgA. No reactivity was found with anti-IgD or anti-IgE. The antibodies were found to be polyclonal as judged by their reactivity with anti-K and anti-X, anti-IgGl, antiIgG3, and anti-IgG4.
The relationship of the immune staining to rheumatoid factor (RF) reactivity was studied by absorption with polymerised human or rabbit IgG. Anti-IgG reactivity was not perceptibly changed, while anti-IgM showed a significant reduction of staining. The decrease in the staining with IgM might be attributed to rheumatoid factor reactivity with bound IgG antibodies.
Some initial studies were carried out to define the specificity of the involved nM cell antigen(s). Exhaustive absorption of the RA sera with pooled human A, B, 0 red blood cells or sheep red blood cells failed to reduce the immune staining of nM cells. On the other hand absorption with bovine red blood cells abolished the immunoactivity of the sera to these cells. Absorption with polymerised bovine serum had no such effect. No cross-reactivity with collagen occurred as judged by lack of reduction in immunostaining after absorption of pooled RA sera with insoluble bovine collagen. A pool of 3 positive sera also failed to stain reticulin"3 in frozen sections of rat kidney and liver in the indirect fluorescent test.
Discussion
The present study demonstrates the presence of reactive antibodies to rat nM cells in sera of a high percentage of our patients with RA. The exact identity of the cultured cardiac non-muscle cells is not clear. They seem to consist of cardiac interstitial mesenchymal cells such as fibroblasts, pericytes, and possibly macrophages." " We could show that they do not contain muscle markers such as desmin and myosin nor the endothelial marker coagulation factor VIII (paper in preparation). These nM cells lack Fc receptors and thus are suitable for immunohistochemical work without interference of non-specific Fc binding on to the cells. We encountered such interference in some preliminary experiments with neonatal rat spleen fibroblasts.
The presence of antibodies reactive with these cells in the majority of active rheumatoid arthritic patients regardless of treatment or seropositivity for rheumatoid factor is of considerable interest and could contribute to the cardiotoxicity. The antibodies were found mainly in the IgG class and were capable of complement fixation. The reason for the incomplete cytotoxic effect on the nM cells is not clear, since the nM cells were previously found to be sensitive to complement-mediated cytotoxicity by rabbit and rat antisera. Heterogeneity of the cells, cell cycle differences in antigen expression, and immunomodulation of the antigens could explain the partial cytotoxicity. In preliminary studies attachment of human C3 to only a minority of nM cells coated with RA sera was found. At least one of the antigens recognised by the positive rheumatoid arthritis sera is a surface antigen and thus different from antibodies reactive with fibroblasts, reported recently.8 It is also different from known heterophile antigens, antibodies to which were described in rheumatoid arthritis sera."6 The absorption experiments with bovine red blood cells indicate cross-reactivity with nM cells. A similar cross-reactivity was reported between heart connective tissue antigens and bovine red blood cells with sera from rheumatic fever patients."7
Antibodies reactive with native and denatured collagen are present in a proportion of rheumatoid arthritis.2 " The possibility that the antibodies described here recognise young collagen known to be secreted by various cultured cells was not excluded in the present study. However, the negative findings with collagen absorption and the use of early cultures grown in the absence of ascorbic acid seem to negate this possibility. Similar negative results were reported recently in studies of cultured synovial fibroblasts."8
Since several nM positive sera failed to react with rat kidney and liver, the antibodies seem to differ from the non-complement-fixing reticulin antibodies described in a small percentage of rheumatoid arthritis patients."3
The significance of the nM antibodies in relation to pathogenesis of cardiac lesions and their use in diagnosis remain to be determined. The antibodies described here might be the result of heart damage9 or alternatively may represent an additional manifestation of the immunological imbalance of the disease. Further correlative studies encompassing a larger series of patients are needed in order to clarify this point.
Finally, our findings might be of practical use in the recognition and immune elimination of non-muscle cells from mixed cardiac cell populations prepared for tissue culture, thus improving pure muscle cell growth without unwanted contaminants. 
